Slow Down, You Move Too Fast
Self-Assembling Drugs Have Antibody, Nanotube, Payload
By Anette Breindl
Tuesday, October 1, 2013
“There’s been a lot of effort over the past decade to use nanomaterials as delivery vehicles,” David Scheinberg told BioWorld Today. But in practice, that effort has often hit snags, due to the way the body deals with those nanomaterials. Specifically, once nanoparticles are combined with their payload, they often assume the sort of shape that gets them targeted for disposal via the liver or spleen. And there, they often are cleared slowly.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.